Learn About Abdominal Obesity Metabolic Syndrome

What is the definition of Abdominal Obesity Metabolic Syndrome?
Abdominal obesity metabolic syndrome is a disease that is influenced by both genetic and environmental factors characterized by a clustering of insulin resistance, high levels of insulin, abnormal blood fats (lipids), high blood pressure, abdominal obesity, glucose intolerance or non-insulin dependent diabetes mellitus, and an increased risk of adverse cardiovascular events. There are different types of abdominal obesity metabolic syndrome, such as abdominal obesity metabolic syndrome 1 or 4. Factors that influence the development of abdominal obesity metabolic syndrome include age, smoking, alcohol, diet, and physical inactivity. Abdominal obesity metabolic syndrome occurs most often in Mexican American women.
Save information for later
Sign Up
What are the symptoms of Abdominal Obesity Metabolic Syndrome?
Symptoms of abdominal obesity metabolic syndrome may include chest pain; radiating pain in chest, jaw, or down left arm (angina pectoris); swelling; abdominal obesity; high blood pressure; high blood triglycerides and low high-density lipoprotein levels; high fasting glucose levels; type 2 diabetes; coronary heart disease (plaque build-up in arteries; CHD); heart attack; and cardiac death.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Abdominal Obesity Metabolic Syndrome?
Treatment for abdominal obesity metabolic syndrome focuses first on lifestyle changes, such as weight loss, exercise, healthy diet, and quitting smoking. Medications for treating abdominal obesity metabolic syndrome may include diabetes drugs; statins to lower blood lipids (fats), such as atorvastatin; blood pressure medications; and blood-thinning medications, such as aspirin or clopidogrel to prevent blood clots.
Who are the top Abdominal Obesity Metabolic Syndrome Local Doctors?
Learn about our expert tiers
Learn more
What are the latest Abdominal Obesity Metabolic Syndrome Clinical Trials?
Global Research Initiative for Patients Screening on NASH - Implementation of an International Transmural Patient Care Pathway

Summary: GRIP on NASH will assist primary care physicians and clinicians to implement the latest patient care pathway, as described by the European Association for the Study of the Liver (EASL), to identify patients at risk of severe fatty liver disease and to raise awareness on fatty liver disease. The primary objective is to implement a transmural patient care pathway, in order to identify patients with ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults Greater Than or Equal to 55 Years Old. A Double-Blinded Randomized Controlled Clinical Trial.

Background: In Alzheimer s disease (AD) the brain cannot use glucose as a fuel. The brain can use ketones as a fuel instead of glucose. Researchers want to test a supplement, Ketone Ester (KE). It may improve brain metabolic function and cognition in normal people and, perhaps, down the road, in patients with AD.

What are the Latest Advances for Abdominal Obesity Metabolic Syndrome?
The long-term (five years) effects of prednisone therapy in children with frequently relapsing nephrotic syndrome: A controlled study of anthropometric parameters and metabolic abnormalities.
Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial.
Tired of the same old research?
Check Latest Advances
Effect of dietary approaches to stop hypertension (DASH) diet, high in animal or plant protein on cardiometabolic risk factors in obese metabolic syndrome patients: A randomized clinical trial.